225 related articles for article (PubMed ID: 36781872)
21. Structural basis for ultrapotent antibody-mediated neutralization of human metapneumovirus.
Banerjee A; Huang J; Rush SA; Murray J; Gingerich AD; Royer F; Hsieh CL; Tripp RA; McLellan JS; Mousa JJ
Proc Natl Acad Sci U S A; 2022 Jun; 119(25):e2203326119. PubMed ID: 35696580
[TBL] [Abstract][Full Text] [Related]
22. Comparison of severe pneumonia caused by Human metapneumovirus and respiratory syncytial virus in hospitalized children.
Wang Y; Ji W; Chen Z; Yan YD; Shao X; Xu J
Indian J Pathol Microbiol; 2014; 57(3):413-7. PubMed ID: 25118733
[TBL] [Abstract][Full Text] [Related]
23. Engineering, Structure and Immunogenicity of the Human Metapneumovirus F Protein in the Postfusion Conformation.
Más V; Rodriguez L; Olmedillas E; Cano O; Palomo C; Terrón MC; Luque D; Melero JA; McLellan JS
PLoS Pathog; 2016 Sep; 12(9):e1005859. PubMed ID: 27611367
[TBL] [Abstract][Full Text] [Related]
24. Lung CD8+ T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8+ T Cells.
Wen SC; Schuster JE; Gilchuk P; Boyd KL; Joyce S; Williams JV
J Virol; 2015 Sep; 89(17):8713-26. PubMed ID: 26063431
[TBL] [Abstract][Full Text] [Related]
25. Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins.
Mousa JJ; Binshtein E; Human S; Fong RH; Alvarado G; Doranz BJ; Moore ML; Ohi MD; Crowe JE
PLoS Pathog; 2018 Feb; 14(2):e1006837. PubMed ID: 29470533
[TBL] [Abstract][Full Text] [Related]
26. Antibody Epitopes of Pneumovirus Fusion Proteins.
Huang J; Diaz D; Mousa JJ
Front Immunol; 2019; 10():2778. PubMed ID: 31849961
[TBL] [Abstract][Full Text] [Related]
27. Chimeric
Olmedillas E; Cano O; Martínez I; Luque D; Terrón MC; McLellan JS; Melero JA; Más V
EMBO Mol Med; 2018 Feb; 10(2):175-187. PubMed ID: 29217660
[TBL] [Abstract][Full Text] [Related]
28. A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys.
Tang RS; Mahmood K; Macphail M; Guzzetta JM; Haller AA; Liu H; Kaur J; Lawlor HA; Stillman EA; Schickli JH; Fouchier RA; Osterhaus AD; Spaete RR
Vaccine; 2005 Feb; 23(14):1657-67. PubMed ID: 15705469
[TBL] [Abstract][Full Text] [Related]
29. Rational design of human metapneumovirus live attenuated vaccine candidates by inhibiting viral mRNA cap methyltransferase.
Zhang Y; Wei Y; Zhang X; Cai H; Niewiesk S; Li J
J Virol; 2014 Oct; 88(19):11411-29. PubMed ID: 25056882
[TBL] [Abstract][Full Text] [Related]
30. Infection and maturation of monocyte-derived human dendritic cells by human respiratory syncytial virus, human metapneumovirus, and human parainfluenza virus type 3.
Le Nouën C; Munir S; Losq S; Winter CC; McCarty T; Stephany DA; Holmes KL; Bukreyev A; Rabin RL; Collins PL; Buchholz UJ
Virology; 2009 Mar; 385(1):169-82. PubMed ID: 19128816
[TBL] [Abstract][Full Text] [Related]
31. Profiling of hMPV F-specific antibodies isolated from human memory B cells.
Xiao X; Fridman A; Zhang L; Pristatsky P; Durr E; Minnier M; Tang A; Cox KS; Wen Z; Moore R; Tian D; Galli JD; Cosmi S; Eddins MJ; Sullivan NL; Yan X; Bett AJ; Su HP; Vora KA; Chen Z; Zhang L
Nat Commun; 2022 May; 13(1):2546. PubMed ID: 35538099
[TBL] [Abstract][Full Text] [Related]
32. Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection.
Liang B; Munir S; Amaro-Carambot E; Surman S; Mackow N; Yang L; Buchholz UJ; Collins PL; Schaap-Nutt A
J Virol; 2014 Apr; 88(8):4237-50. PubMed ID: 24478424
[TBL] [Abstract][Full Text] [Related]
33. Structure-Based Design and Antigenic Validation of Respiratory Syncytial Virus G Immunogens.
Nuñez Castrejon AM; O'Rourke SM; Kauvar LM; DuBois RM
J Virol; 2022 Apr; 96(7):e0220121. PubMed ID: 35266806
[TBL] [Abstract][Full Text] [Related]
34. Serological cross-reactivity of members of the Metapneumovirus genus.
Alvarez R; Jones LP; Seal BS; Kapczynski DR; Tripp RA
Virus Res; 2004 Sep; 105(1):67-73. PubMed ID: 15325082
[TBL] [Abstract][Full Text] [Related]
35. Comparison of human metapneumovirus, respiratory syncytial virus and influenza A virus lower respiratory tract infections in hospitalized young children.
Wolf DG; Greenberg D; Kalkstein D; Shemer-Avni Y; Givon-Lavi N; Saleh N; Goldberg MD; Dagan R
Pediatr Infect Dis J; 2006 Apr; 25(4):320-4. PubMed ID: 16567983
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Clinical Characteristics of Human Metapneumovirus and Respiratory Syncytial Virus Infections in Hospitalized Young Children.
Taniguchi A; Kawada JI; Go K; Fujishiro N; Hosokawa Y; Maki Y; Sugiyama Y; Suzuki M; Tsuji T; Hoshino S; Muramatsu H; Kidokoro H; Kinoshita F; Hirakawa A; Takahashi Y; Sato Y; Natsume J;
Jpn J Infect Dis; 2019 Jul; 72(4):237-242. PubMed ID: 30814460
[TBL] [Abstract][Full Text] [Related]
37. Comparing Human Metapneumovirus and Respiratory Syncytial Virus: Viral Co-Detections, Genotypes and Risk Factors for Severe Disease.
Moe N; Krokstad S; Stenseng IH; Christensen A; Skanke LH; Risnes KR; Nordbø SA; Døllner H
PLoS One; 2017; 12(1):e0170200. PubMed ID: 28095451
[TBL] [Abstract][Full Text] [Related]
38. Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge.
Gilbert BE; Patel N; Lu H; Liu Y; Guebre-Xabier M; Piedra PA; Glenn G; Ellingsworth L; Smith G
Vaccine; 2018 Dec; 36(52):8069-8078. PubMed ID: 30389195
[TBL] [Abstract][Full Text] [Related]
39. A Parainfluenza Virus Vector Expressing the Respiratory Syncytial Virus (RSV) Prefusion F Protein Is More Effective than RSV for Boosting a Primary Immunization with RSV.
Liang B; Matsuoka Y; Le Nouën C; Liu X; Herbert R; Swerczek J; Santos C; Paneru M; Collins PL; Buchholz UJ; Munir S
J Virol; 2020 Dec; 95(2):. PubMed ID: 33115876
[TBL] [Abstract][Full Text] [Related]
40.
van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O
J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
